Zoetis is going to be a part of the J.P. Morgan Healthcare Conference, which is a clear indication of the company’s ongoing conversation with the investment community worldwide. Zoetis, the largest animal healthcare company in the world, is steadfast in its mission to improve animal health through innovative solutions and a deep-rooted commitment. Furthermore, the firm is concentrating on giving a hand to veterinarians, pet owners, and livestock producers all over the globe. This conference is an important stage for Zoetis to communicate its plans and expectations for the future.
The company will attend the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026. Kristin Peck, Chief Executive Officer, and Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent Zoetis. They will respond to analyst questions at 10:30 a.m. PT. Therefore, investors will gain direct insight into Zoetis’ business priorities and market positioning.
For more than 70 years, Zoetis has focused on predicting, preventing, detecting, and treating animal illness. As a result, the company has built a strong foundation in animal health innovation. Furthermore, Zoetis continues to expand solutions that improve animal well-being and support sustainable care practices.
The J.P. Morgan Healthcare Conference remains the industry’s largest and most influential healthcare investment event. It brings together global industry leaders, fast-growing companies, technology innovators, and members of the investment community. Consequently, the conference serves as a critical forum for discussion, insight sharing, and long-term investment perspectives.
Explore Health Tech Insiders for the latest medical innovations and reliable strategic insights driving the future of technology-driven healthcare transformation.
News Source: Businesswire.com
